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pen access Abstract Background: Patients undergoing orthotopic liver transplantation are subjected to
severe hemodynamic and metabolic derangements, close monitoring are always required. Mixed
venous oxygen saturation (SVO2) is often used to reﬂect supply/demand ration for oxygen in crit-
ically ill patients. Cardiac output (CO) and serum lactate levels are also sensitive markers for detect-
ing early hemodynamic and metabolic changes. Patients with end-stage liver disease, possess
hemodynamic and metabolic derangements that can render such tools insensitive. In the current
trial we evaluated SVO2, CO and serum lactate and since SVO2 can sometimes be misleading espe-
cially in hyperdynamic status we assessed oxygen delivery (DO2) and oxygen consumption (VO2).
Patients and methods: Twenty patients with end-stage liver disease scheduled for live related liver
transplantation were enrolled, CO, SVO2, serum lactate levels, VO2 and DO2 were recorded during
the following times; dissection phase (T1), an-hepatic phase (T2) and neo-hepatic phase (T3).
Results: All recorded parameters were comparable among the three phases of liver transplantation
except for serum lactate levels that had increased signiﬁcantly during T2 (7.10 ± 3.5 mmol/l,
P= 0.04) and T3 (9.42 ± 4.65 mmol/l, P= 0.001) compared T1 (3.28 ± 2.7 mmol/l), however
serum lactate levels and T2 and T3 were comparable. There was no evidence of any correlation
among CO, SVO2, serum lactate levels, VO2 and DO2.
Conclusion: Increase in serum lactate in this patient population is not necessarily due to increased
production as a consequence of tissue hypoperfusion but rather may reﬂect improper lactate utili-
zation since indicators of global tissue perfusion acted independently.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.M.N. El Shafei).
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Patients with end-stage liver disease undergoing orthotopic
liver transplantation are subjected to profound hemodynamic
and metabolic changes. During the dissection phase bleeding
and hypovolaemia are common [1], while in the an-hepatic
phase there may be reduction in venous return, with subse-
quent reduction in left ventricular preload [2] and following
declamping and starting of the neo-hepatic phase reperfusion
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lead to serious consequences [3]. In an attempt to minimize
such effects, close, invasive and intense monitoring is usually
required. The use of serum lactate levels had been introduced
as a marker of unfavorable outcome in critically ill patients
especially those with sepsis [4,5], as serum lactate had been
widely used as an indicator of tissue hypoxia [6]. Moreover va-
lue of monitoring venous oxygen saturation among patients
undergoing such procedure is beneﬁcial [7], as venous oxygen
saturation can detect early changes in hemodynamic and met-
abolic status of critically ill patients [8], there are increasing
evidence describing patterns of mixed venous oxygen satura-
tion (SVO2) and central venous oxygen saturation (ScVO2)
[9,10] monitoring during surgery, in addition to evidence from
septic patients [11] rendering estimation of venous saturation
acts as a guide for therapeutic interventions. Recently, SVO2
and ScVO2 among patients undergoing liver transplantation
had been assessed and proved to show marked agreement [7]
provided that ScVO2 was higher than SVO2, however in
healthy individuals, ScvO2 is slightly less than SvO2 [12] be-
cause the lower extraction ratio by the kidneys leaves a high
oxygen content in the inferior vena cava. However, in low ﬂow
states or in shock, this gradient can be reversed by redistribu-
tion of blood ﬂow associated with greater reduction in renal
and splanchnic blood ﬂow [13]. As various organs display
physiological differences in oxygen delivery (DO2) and con-
sumption (VO2), also DO2 and VO2 can change rapidly under
pathophysiological conditions, yielding SVO2 information on
adequate tissue oxygenation unreliable specially when not con-
tinuously monitored (intermittent analysis). Furthermore, sev-
eral diseases such as hepatic failure or severe sepsis with
arterio–venous shunting limit the interpretation of absolute
SVO2 values as indicators of tissue oxygenation [14]. Thus
intermittent venous saturations can be sometimes misleading
regard to reﬂection of global tissue perfusion, since venous sat-
uration reﬂects global tissue perfusion that relies on supply de-
mand ratio for oxygen. So it is more logic to assess DO2 and
VO2 directly, rather than SVO2 especially if a pulmonary ar-
tery catheter (PAC) will be in place. In the current study we as-
sessed changes in DO2, VO2 and SVO2 to changes in cardiac
output and serum lactate in patients undergoing orthotopic
live donor liver transplantation. Our hypothesis is that DO2,
VO2 and SVO2 will not provide additional data that can aid
in patient management.2. Materials and methods
After approval of the local Ethics Committee and obtaining
written informed consent, the study was designed to include
20 American Society of Anesthesiologist physical status
(ASA) III or IV patients with end-stage liver disease, scheduled
for orthotopic liver transplantation between 2007 and 2008.
Induction of anesthesia was performed using propofol, fenta-
nyl and atracurium. Anesthesia was maintained with sevoﬂu-
rane adjusted between 1% and 2% in an air/oxygen mixture,
fentanyl infusion at 1–2 lg kg1 h1 and atracurium infusion
at 0.5 mg kg1 h1. Mechanical ventilation was provided using
a tidal volume of 8–10 ml kg1 with the respiratory rate
adjusted to maintain the PaCO2 between 30 and 35 mmHg.
All patients were monitored for temperature, noninvasive
and invasive arterial blood pressure, ﬁve lead ECG, peripheraloxygen saturation, end-tidal carbon dioxide tension, hourly
urinary output, and central venous pressure (CVP). A 7-Fr tri-
ple lumen CVP catheter (Arrow International Inc., Reading,
PA, USA) was inserted into the right internal jugular vein. A
pulmonary artery catheter (Abbott Laboratories, North Chi-
cago, IL, USA) was also inserted into the right internal jugular
vein. Intravascular electrocardiography was used to conﬁrm
the placement of the CVP catheter in the lower superior vena
cava directly above the junction of superior vena cava with the
right atrium. The pulmonary artery catheter (PAC) was posi-
tioned using wedge pressure and conﬁrmed with ﬂuoroscopy.
Liver transplantation was performed with preservation of the
retrohepatic caval vein (the piggyback technique). Blood sam-
ples were obtained simultaneously from the pulmonary artery
catheter and from arterial line during dissection (T1, 60 min
following skin incision), anhepatic (T2, immediately after re-
moval of the diseased liver) and neo-hepatic phases (T3, fol-
lowing anastomosis of hepatic artery). All samples obtained
from the pulmonary artery catheter were withdrawn over
30 s using a low-negative pressure technique and never with
the balloon inﬂated; a standard volume of 1.5 ml of blood
was obtained and analyzed for mixed venous oxygen satura-
tion. Also 1.5 ml of blood was obtained from arterial line
and sent for analysis using a co-oximeter (ABL 700; Radiom-
eter, Copenhagen, Denmark) that allows measuring serum lac-
tate levels and the device is calibrated daily. All samples were
obtained after withdrawal of dead space and ﬂushing ﬂuid.
Since no evidence supporting superiority of venous versus arte-
rial serum lactate levels [15,16], in the current study we used
serum lactate levels obtained from the arterial sample. Imme-
diately after series of blood samples were drawn, cardiac out-
put (CO) was recorded. CO was determined by the
thermodilution technique using triplicate method, where three
measurements were obtained and averaged using the PAC.
Arterial–venous oxygen content difference (CaO2–CvO2)
was measured as
CaO2–CvO2 ¼ ½Hb 1:36 ðSaO2=100Þ
þ ð0:0031 PaO2Þ Hb 1:36 ðSVO2=100Þ
þ ð0:0031 PVO2Þ;
VO2 was calculated as CO (dl/min) · (CaO2  CvO2), while
DO2 was calculated as CaO2 · CO (dl/min). Serum hemoglo-
bin was calculated using the venous sample, since venous sam-
ples offers better precision than arterial sample [17].
3. Statistical analysis
Data are expressed as mean ± SD, hemodynamic, metabolic
and oxygenation parameters were analyzed using one way
ANOVA where phases (T1–T3) were the independent vari-
ables, if statistical signiﬁcance was reached a Tukey post hoc
test was performed to identify level of signiﬁcance. Pearson
correlation was performed using individual changes in VO2,
DO2, SVO2, CO and serum lactate. P< 0.05 was considered
as statistically signiﬁcant. SPSS v.15.0 for windows was used
for statistical analysis.4. Results
Twenty patients with end-stage liver disease (Child C) were
enrolled, 18 males and 2 females. Their mean age was 47.2
Figure 1 Demonstrates serum lactate levels (mmol/l) among
various stages of orthotropic liver transplantation. T1 = dissec-
tion phase, T2 = an-hepatic phase and T3 = neo-hepatic phase.
*Denotes signiﬁcantly lower compared to T2 (P= 0.04). Denotes
signiﬁcantly lower compared to T3 (P= 0.001).
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having transplantation due to hepatitis C virus, four patients
due to hepatocellular carcinoma and one patient with autoim-
mune hepatitis. Serum lactate level recorded during dissection
phase (T1) was signiﬁcantly lower compared to those recorded
at anhepatic and neo-hepatic phases (T2 and T3); however
serum lactate values recorded during T2 and T3 were compa-
rable (3.28 ± 2.7, 7.10 ± 3.5 and 9.42 ± 4.65 mmol/l, respec-
tively) (Fig. 1). All other recorded parameters were
comparable among different phases of liver transplantation
(T1–T3) (Table 1).
Changes in serum lactate levels and cardiac output did not
demonstrate correlation with any of the measured parameters.
Also changes in SVO2 did not demonstrate meaningful corre-
lations with DO2 and VO2 (Figs. 2–4).
5. Discussion
The ﬁnding in the current study can be summarized as follows:
(a) serum lactate among patients with end-stage liver disease
had signiﬁcantly increased during an-hepatic and neo-hepatic
phases compared to those during dissection phase, despite
comparable hemodynamic and oxygenation parameters; (b)
parameters as serum lactate levels, cardiac output and mixed
venous oxygen saturations that are commonly used to reﬂect
global tissue perfusion do not possess a meaningful correlationTable 1 Demonstrates mean (SD) of all measured parameters duri
Variable T1
pH 7.36 (0.06)
Hb (g/dl) 8.93 (1.74)
CO (l/min) 9.82 (3.16)
CaO2 (ml/100 ml) 13.09 (2.66)
CvO2 (ml/100 ml) 1.40 (0.42)
CaO2–CvO2 (ml/100 ml) 11.69 (2.25)
VO2 (ml/min) 1138.2 (370.1)
DO2 (ml/min) 1274.4 (419.9)
SVO2 (%) 90.3 (3.5)
T1 = dissection phase, T2 = an-hepatic phase and T3 = neo-hepatic ph
CaO2 = arterial oxygen content, CvO2 = venous oxygen content, CaO2
consumption, DO2 = oxygen delivery and SVO2 = mixed venous oxygennot only between each other but also with oxygen delivery and
consumption among patients undergoing live donor liver
transplantation.
In general increased serum lactate levels are either due to in-
creased lactate production or reduced lactate uptake and clear-
ance. Increased lactate production is almost always attributed
to cellular hypoxia and treatment should be directed to opti-
mize DO2, however in the current study we demonstrated high
serum lactate levels despite adequate DO2. Thus lactate in-
crease in the current situation is independent of oxygen deliv-
ery, and such ﬁnding had been previously observed in septic
patients [18]. Thus the possible mechanism for increased serum
lactate levels in the current trial can be linked mainly to im-
paired lactate uptake and utilization by the liver. Nevertheless
increased lactate production can still occur due to abnormal
metabolic consequences including increased glycolysis or mus-
cle catabolism [19]. Regardless of the mechanism responsible
for increased lactate, it is obvious that anaerobic metabolism
is not the key player, and monitoring of serum lactate in the
current situation reﬂects more lactate utilization rather than
lactate production. Levraut and colleagues [20] demonstrated
in 34 hemodynamically stable septic patients that mild hyper-
lactatemia is primarily due to defect in lactate utilization rather
than defects in cellular oxygenation. Also Hamamoto and col-
leagues [21] found that serum lactate levels had increased de-
spite normal hemodynamic and mixed venous oxygen
saturation in pediatric patients who underwent the Fontan
procedure for congenital heart disease. Also in the current trial
lack of correlation between changes in lactate (D lactate) ver-
sus changes in all other parameters (Fig. 3) denotes that
changes in lactate levels is independent from changes in such
parameters in this speciﬁc patient population.
Mixed venous oxygen saturation is a commonly used
parameter to reﬂect balance between oxygen delivery and oxy-
gen consumption, in the current study we demonstrated lack of
correlation between changes in SVO2 versus VO2 and DO2
(Fig. 4). Jugan and colleagues [22] monitored mixed venous
oxygen saturation among 30 patients undergoing liver trans-
plantation demonstrated lack of correlation between SVO2
and VO2, also demonstrated signiﬁcant but Poor correlation
with cardiac output. The results in the current study show great
agreement with Jugan ﬁndings except for that the correlation of
SVO2 was not only poor but insigniﬁcant (Fig. 2). Also Ino-
mata [23] showed lack of correlation among changes in SVO2
and VO2 in cardiac surgery. Although oxygen consumption isng various stages of liver transplantation.
T2 T3 P
7.35 (0.04) 7.30 (0.07) 0.07
8.69 (1.61) 8.23 (1.08) 0.37
9.93 (4.24) 10.78 (4.04) 0.80
12.95 (2.35) 12.51 (1.61) 0.81
1.48 (0.66) 1.21 (0.26) 0.37
11.47 (2.03) 11.30 (1.36) 0.89
1102.3 (370.4) 1186.0 (366.9) 0.86
1251.6 (448.4) 1310.9 (402.4) 0.94
92.8 (3.2) 89.3 (4.1) 0.06
ase. Hb = serum hemoglobin concentration, CO= cardiac output,
–CvO2 = arterio–venous oxygen content difference, VO2 = oxygen
saturation.
Figure 2 (A) Changes in serum lactate (mmol/l) versus changes in cardiac output (l/min); (B) changes in serum lactate (mmol/l) versus
changes in mixed venous oxygen saturation (%); (C) changes in serum lactate (mmol/l) versus changes in oxygen delivery (ml/min) and (D)
changes in serum lactate (mmol/l) versus changes in oxygen consumption (ml/min).
Figure 3 (A) Changes in cardiac output (ml/min) versus changes in mixed venous oxygen saturation (%); (B) changes in cardiac output
(l/min) versus changes oxygen delivery (ml/min) and (C) changes in cardiac output (l/min) versus changes oxygen consumption (ml/min).
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Figure 4 (A) Changes in mixed venous oxygen saturation (%) versus changes in oxygen consumption (ml/min) and (B) changes in mixed
venous oxygen saturation (%) versus changes in delivery (ml/min).
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however we demonstrated very high values for VO2 that was
not paralleled by decrease in SVO2. This phenomenon can be
explained by the fact that oxygen delivery (DO2) had increased
signiﬁcantly and thus the balance between DO2 and VO2 was
maintained. Such increase in DO2 can be primarily attributed
to increase in cardiac output (Table 1). High cardiac output
is primarily due to hyperdynamic circulation that is a persistent
ﬁnding in patients with end-stage liver disease and character-
ized by both increase in heart rate and cardiac output with de-
creased systemic vascular resistance [24,25].
Also we demonstrated high SVO2 values (Table 1) and lack
of correlation between CO and SVO2. Similar ﬁndings had
been reported by El-Masry and colleagues [7] among similar
patient population. Also in the current study we estimated ac-
tual VO2 and DO2 in an attempt to demonstrate a meaningful
relationship instead of relying on SVO2 that was consistently
high and independent on cardiac output. However VO2 and
DO2 relationship to CO did not differ from those with SVO2
and CO rendering such patient population in a unique situa-
tion. Metabolic (high serum lactate levels), hemodynamic
(hyperdynamic circulation) and oxygenation parameters
(SVO2, DO2 and VO2) in such patient population were inde-
pendent from each other and no effective relationship could
be identiﬁed, unlike many clinical conditions where CO,
SVO2 and serum lactate are considered the golden monitors
for tissue perfusion and are usually used as goal oriented
hemodynamic therapy [11,26,27]. In the current situation we
agree with Crescenzi and colleagues, who encouraged compre-
hensive understanding of pathophysiology of hemodynamic
changes prior to initiation of therapy [28].
Limitations included that all enrolled patients were hemo-
dynamically stable and we cannot extrapolate such ﬁndings
in patients with different hemodynamic conditions. The main
stay behind this trial was that we observed marked increase
in serum lactate in such patients despite acceptable hemody-
namic and metabolic parameters. So we decided to study such
phenomenon in an attempt to understand the reason for in-
creased serum lactate thus we decided to study 20 patients as
pilots but due to negative results we did not enroll further pa-
tients using proper power analysis.
6. Conclusion
Markers of global tissue perfusion in patients undergoing
orthotopic liver transplantation with end-stage liver diseasedemonstrated a predictable pattern and the use of such tools
in hemodynamically stable patients did not provide additional
value and did not parallel metabolic derangements reﬂected by
increased serum lactate levels.References
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